thrombocytopenia

Eisai Presents Latest Data of Phase I Clinical Trial on Liposomal Formulation of Anti-Cancer Agent Halaven (Eribulin) at ESMO Virtual Congress 2020

Tokyo, September 18, 2020: Eisai Co., Ltd. has announced that the latest results from the cohort targeting patients with HER2-negative…

4 years ago

Gland Pharma Announces Launch of the First Novel Non-Frozen Ready-To-Use Bivalirudin

Mumbai, June 08, 2020: Gland Pharma Ltd. (Gland Pharma), along with its partners MAIA Pharmaceuticals, Inc. (MAIA) and Athenex Pharmaceutical…

4 years ago